{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:51:29Z","timestamp":1782478289199,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jgo.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T15:34:13Z","timestamp":1639236853000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Electronic FRAIL score as a predictor of treatment outcomes in older patients with diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Jesse","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Disperati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Elinder-Camburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jgo.2021.12.005_bb0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/10428194.2014.935364","article-title":"Prognostic significance of geriatric assessment in combination with laboratory parameters in older patients with aggressive non-Hodgkin lymphoma","volume":"56","author":"Aaldriks","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.jgo.2021.12.005_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jgo.2021.12.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2019-0738","article-title":"Comprehensive geriatric assessment (cga): a simple tool for guiding the treatment of older adults with diffuse large b-cell lymphoma in China","volume":"25","author":"Bai","year":"2020","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.jgo.2021.12.005_bb0025","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1080\/10428194.2018.1443332","article-title":"Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era","volume":"59","author":"Beygi","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2021.12.005_bb0030","article-title":"Electronic FRAIL score may predict treatment outcomes in older adults with myeloma","author":"Chan","year":"2020","journal-title":"J Geriat Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2021.12.005_bb0035","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jgo.2021.12.005_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgo.2016.02.007","article-title":"Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research","volume":"7","author":"Magnuson","year":"2016","journal-title":"J Geriat Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2021.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.20.02465","article-title":"Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi","volume":"39","author":"Merli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2021.12.005_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jgo.2014.11.004","article-title":"Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper","volume":"6","author":"Morrison","year":"2015","journal-title":"J Geriat Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2021.12.005_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jgo.2021.12.005_bb0060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1634\/theoncologist.2011-0355","article-title":"Tailored therapy in an unselected population of 91 elderly patients with dlbcl prospectively evaluated using a simplified cga","volume":"17","author":"Olivieri","year":"2012","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.jgo.2021.12.005_bb0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","article-title":"Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) investigators. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial","volume":"12","author":"Peyrade","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2021.12.005_bb0070","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jgo.2021.12.005_bb0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1634\/theoncologist.2011-0417","article-title":"Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large b-cell lymphoma","volume":"17","author":"Spina","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2021.12.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103294","article-title":"Diffuse large B-cell lymphoma in very elderly patients: towards best tailored treatment \u2013 a systematic review","volume":"160","author":"Tavares","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl_3","key":"10.1016\/j.jgo.2021.12.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afy127.02","article-title":"Assessing the psychometric properties of the HIS \u201cthink frailty\u201d tool","volume":"47","author":"Taylor-Rowan","year":"2018","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.jgo.2021.12.005_bb0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3109\/10428194.2014.953142","article-title":"Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the lymphoma Italian Foundation (FIL)","volume":"56","author":"Tucci","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.jgo.2021.12.005_bib91","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406821002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406821002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:55:39Z","timestamp":1761818139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406821002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1879406821002691"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2021.12.005","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electronic FRAIL score as a predictor of treatment outcomes in older patients with diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}